Johnson & Johnson
COMPANY DATA
Based in the US, Johnson & Johnson operates as a holding company in the healthcare / drug manufacturers - general sector and has been an established market player since its founding in 1887. The company's business model is primarily divided into the Innovative Medicine and MedTech segments. While the former focuses on…
Brief assessment by a strategy agent, last updated on 04/08/2026. Not investment advice.
PRICE HISTORY
1D
-0.8 %
1W
-0.8 %
1M
+1.9 %
6M
+10.6 %
YTD
+31 %
1Y
+53.6 %
2Y
+64.7 %
5Y
+56.8 %
10Y
+127.7 %
EARNINGS
Next earnings date
13/10/2026 (in 48 days)
Volatility around earnings
~18% stronger price swings than usual
SCORES
Valued more expensively than its own historical average.
Very strong uptrend.
Solid balance sheet quality and profitability.
Very stable, well-covered dividend with a growth streak.
Average growth.
Insiders are selling more shares than they buy.
Roughly meets expectations.
Not enough data yet for an assessment.
Negative social media sentiment.
Persistently high short volume ratio, partly with a Reg SHO threshold listing.
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 26/08/2026.
ASK THE AGENTS ABOUT JNJ
ANALYST ASSESSMENT
PRICE TARGET LOW
US$255.00
CONSENSUS
US$282.08
MEDIAN
US$282.00
PRICE TARGET HIGH
US$305.00
0
STRONG BUY
21
BUY
16
HOLD
3
SELL
0
STRONG SELL
40
TOTAL · Buy
| DATE | ANALYST FIRM | RATING | ACTION |
|---|---|---|---|
| 06/08/2026 | Guggenheim | Buy | maintain |
| 03/08/2026 | Wells Fargo | Overweight | maintain |
| 17/07/2026 | Guggenheim | Buy | maintain |
| 16/07/2026 | Raymond James | Outperform | maintain |
| 16/07/2026 | RBC Capital | Outperform | maintain |
| 16/07/2026 | Wells Fargo | Overweight | maintain |
| 16/07/2026 | Morgan Stanley | Overweight | maintain |
| 13/07/2026 | RBC Capital | Outperform | maintain |
METRICS
P/E
31.33
P/B
7.78
EV/EBITDA
20.21
RETURN ON EQUITY
6.5 %
NET MARGIN
21.9 %
DEBT/EQUITY
0.58
DIVIDEND YIELD
1.9 %
AS OF
28/06/2026
FREE FLOAT & LIQUIDITY
FREE FLOAT
99.8 %
FLOAT SHARES
2,405,898,165
AVG. DAILY VOLUME (30D)
7,072,289
INSIDER TRANSACTIONS (SEC)
| DATE | INSIDER | ROLE | TRANSACTION | SHARES | PRICE | PLAN TYPE |
|---|---|---|---|---|---|---|
| 18/08/2026 | Taubert Jennifer L | Officer | Sale | 15,000 | 263.36 | Spontaneous |
| 18/08/2026 | Taubert Jennifer L | Officer | Option exercise | 15,000 | 115.67 | Spontaneous |
| 14/08/2026 | Duato Joaquin | Officer | Option exercise | 123,291 | 115.67 | Spontaneous |
| 14/08/2026 | Duato Joaquin | Officer | Sale | 102,315 | 261 | Spontaneous |
| 14/08/2026 | Duato Joaquin | Officer | Sale | 20,976 | 262 | Spontaneous |
ATTENTION
Price since yesterday: -0.8%
Search (Google Trends)
INSTITUTIONAL HOLDERS
| FUND / INSTITUTION | SHARES | CHANGE | AS OF |
|---|---|---|---|
| BlackRock, Inc. | 212,098,264 | -1,287,282 | 30/06/2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 157,226,374 | +621,004 | 30/06/2026 |
| STATE STREET CORP | 133,776,025 | +299,737 | 30/06/2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 64,370,816 | +856,380 | 30/06/2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 59,086,417 | -78,445 | 30/06/2026 |
DIVIDENDS
| EX-DATE | PAY DATE | AMOUNT | YIELD |
|---|---|---|---|
| 25/08/2026 | 08/09/2026 | US$1.34 | 1.9 % |
| 26/05/2026 | 09/06/2026 | US$1.34 | 2.3 % |
| 24/02/2026 | 10/03/2026 | US$1.30 | 2.1 % |
| 25/11/2025 | 09/12/2025 | US$1.30 | 2.5 % |
| 26/08/2025 | 09/09/2025 | US$1.30 | 2.9 % |
STOCK SPLITS
| DATE | RATIO |
|---|---|
| 13/06/2001 | 2:1 |
| 12/06/1996 | 2:1 |
| 10/06/1992 | 2:1 |
| 11/05/1989 | 2:1 |
| 19/05/1981 | 3:1 |
Not investment advice. Past performance is not an indicator of future results.